| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |